vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and IPG PHOTONICS CORP (IPGP). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $274.5M, roughly 1.9× IPG PHOTONICS CORP). IPG PHOTONICS CORP runs the higher net margin — 4.8% vs -12.3%, a 17.2% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $10.9M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 4.4%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.

GENI vs IPGP — Head-to-Head

Bigger by revenue
GENI
GENI
1.9× larger
GENI
$510.9M
$274.5M
IPGP
Higher net margin
IPGP
IPGP
17.2% more per $
IPGP
4.8%
-12.3%
GENI
More free cash flow
GENI
GENI
$58.6M more FCF
GENI
$69.6M
$10.9M
IPGP
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
4.4%
IPGP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENI
GENI
IPGP
IPGP
Revenue
$510.9M
$274.5M
Net Profit
$-63.0M
$13.3M
Gross Margin
25.2%
36.1%
Operating Margin
-11.5%
1.2%
Net Margin
-12.3%
4.8%
Revenue YoY
17.1%
Net Profit YoY
69.8%
EPS (diluted)
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
IPGP
IPGP
Q4 25
$510.9M
$274.5M
Q3 25
$335.4M
$250.8M
Q2 25
$215.2M
$250.7M
Q1 25
$119.7M
$227.8M
Q4 24
$413.0M
$234.3M
Q3 24
$285.8M
$233.1M
Q2 24
$184.1M
$257.6M
Q1 24
$97.2M
$252.0M
Net Profit
GENI
GENI
IPGP
IPGP
Q4 25
$-63.0M
$13.3M
Q3 25
$7.5M
Q2 25
$-47.3M
$6.6M
Q1 25
$-25.5M
$3.8M
Q4 24
$-85.5M
$7.8M
Q3 24
$-47.1M
$-233.6M
Q2 24
$-35.5M
$20.2M
Q1 24
$-25.2M
$24.1M
Gross Margin
GENI
GENI
IPGP
IPGP
Q4 25
25.2%
36.1%
Q3 25
24.2%
39.5%
Q2 25
19.1%
37.3%
Q1 25
10.7%
39.4%
Q4 24
16.7%
38.6%
Q3 24
20.5%
23.2%
Q2 24
18.6%
37.3%
Q1 24
9.8%
38.7%
Operating Margin
GENI
GENI
IPGP
IPGP
Q4 25
-11.5%
1.2%
Q3 25
-15.3%
3.1%
Q2 25
-21.0%
0.0%
Q1 25
-20.3%
0.8%
Q4 24
-18.0%
6.0%
Q3 24
-13.9%
-108.7%
Q2 24
-16.8%
4.7%
Q1 24
-23.7%
7.6%
Net Margin
GENI
GENI
IPGP
IPGP
Q4 25
-12.3%
4.8%
Q3 25
3.0%
Q2 25
-22.0%
2.6%
Q1 25
-21.3%
1.6%
Q4 24
-20.7%
3.3%
Q3 24
-16.5%
-100.2%
Q2 24
-19.3%
7.8%
Q1 24
-25.9%
9.6%
EPS (diluted)
GENI
GENI
IPGP
IPGP
Q4 25
$0.30
Q3 25
$0.18
Q2 25
$0.16
Q1 25
$0.09
Q4 24
$0.27
Q3 24
$-5.33
Q2 24
$0.45
Q1 24
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
IPGP
IPGP
Cash + ST InvestmentsLiquidity on hand
$280.6M
$839.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$724.5M
$2.1B
Total Assets
$1.1B
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
IPGP
IPGP
Q4 25
$280.6M
$839.3M
Q3 25
$110.2M
$870.4M
Q2 25
$110.2M
$899.6M
Q1 25
$110.2M
$926.9M
Q4 24
$100.3M
$930.2M
Q3 24
$100.3M
$1.0B
Q2 24
$100.3M
$1.1B
Q1 24
$100.3M
$1.1B
Stockholders' Equity
GENI
GENI
IPGP
IPGP
Q4 25
$724.5M
$2.1B
Q3 25
$572.4M
$2.1B
Q2 25
$572.4M
$2.1B
Q1 25
$572.4M
$2.1B
Q4 24
$573.0M
$2.0B
Q3 24
$573.0M
$2.1B
Q2 24
$573.0M
$2.3B
Q1 24
$573.0M
$2.3B
Total Assets
GENI
GENI
IPGP
IPGP
Q4 25
$1.1B
$2.4B
Q3 25
$792.3M
$2.4B
Q2 25
$792.3M
$2.4B
Q1 25
$792.3M
$2.3B
Q4 24
$775.7M
$2.3B
Q3 24
$775.7M
$2.4B
Q2 24
$775.7M
$2.5B
Q1 24
$775.7M
$2.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
IPGP
IPGP
Operating Cash FlowLast quarter
$81.9M
$28.8M
Free Cash FlowOCF − Capex
$69.6M
$10.9M
FCF MarginFCF / Revenue
13.6%
4.0%
Capex IntensityCapex / Revenue
2.4%
6.5%
Cash ConversionOCF / Net Profit
2.17×
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$-3.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
IPGP
IPGP
Q4 25
$81.9M
$28.8M
Q3 25
$-4.8M
$35.3M
Q2 25
$-1.2M
$-2.2M
Q1 25
$-14.6M
$13.4M
Q4 24
$14.9M
$73.8M
Q3 24
$-9.2M
$66.1M
Q2 24
$53.5M
Q1 24
$54.6M
Free Cash Flow
GENI
GENI
IPGP
IPGP
Q4 25
$69.6M
$10.9M
Q3 25
$-14.2M
$14.6M
Q2 25
$-5.8M
$-17.6M
Q1 25
$-16.0M
$-11.4M
Q4 24
$11.3M
$50.6M
Q3 24
$-11.6M
$43.0M
Q2 24
$29.2M
Q1 24
$26.5M
FCF Margin
GENI
GENI
IPGP
IPGP
Q4 25
13.6%
4.0%
Q3 25
-4.2%
5.8%
Q2 25
-2.7%
-7.0%
Q1 25
-13.4%
-5.0%
Q4 24
2.7%
21.6%
Q3 24
-4.1%
18.4%
Q2 24
11.3%
Q1 24
10.5%
Capex Intensity
GENI
GENI
IPGP
IPGP
Q4 25
2.4%
6.5%
Q3 25
2.8%
8.3%
Q2 25
2.1%
6.1%
Q1 25
1.2%
10.9%
Q4 24
0.9%
9.9%
Q3 24
0.9%
9.9%
Q2 24
9.4%
Q1 24
11.1%
Cash Conversion
GENI
GENI
IPGP
IPGP
Q4 25
2.17×
Q3 25
4.73×
Q2 25
-0.34×
Q1 25
3.58×
Q4 24
9.44×
Q3 24
Q2 24
2.65×
Q1 24
2.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

IPGP
IPGP

Materials Processing$232.8M85%
Laser And Non Laser Systems$38.8M14%
Transferred Over Time$5.3M2%

Related Comparisons